top of page

Know your implant
health. Sooner.

In development

Mammoptix is building the first at-home wearable designed for continuous breast-implant monitoring, so you never have to simply wait and wonder between check-ups.

Millions of women. Almost no monitoring.

The need

More than 55 million women live with breast implants, and implants are not lifetime devices. Yet between check-ups there is often little to reassure you. Today's follow-up relies on occasional imaging that can be costly and hard to access, so many women are left waiting and wondering. We think there is a better way.

Convenience

At home

A soft, wearable bra you use in the comfort of your own home.

Experience

Care

Connected to your clinician

Your insights can be shared securely with your healthcare provider.

Painless and quick

A gentle scan of about ten minutes, discreet and radiation-free.

how it works

1

Wear and scan

Put on the Mammoptix bra and

start a scan from the app.

Simple by design.

2

The technology reads the signal and AI are designed to turn the measurement into clear, understandable insights.

3

Stay informed together

You and your clinician can follow trends over time and decide together on next steps.

“We are moving breast-implant care from occasional and reactive to continuous and reassuring. That is preventive care made simple, smart and deeply human.”

why coose us

FOR WOMEN

Peace of mind, between the appointments

If you have breast implants, you deserve to feel informed and in control, not left waiting. Mammoptix is being designed to help you monitor your implant health from home. It is not a diagnosis or a replacement for your doctor or medical imaging.

FOR CLINICIANS

Continuous insight, better follow-up

Mammoptix is being developed to give breast clinics and surgeons a practical way to support patients between visits, with summarised insights and full data access, designed to make follow-up more efficient.

BUILT ON SCIENCE

With the right partners.

Our approach uses a validated measurement technique, combined with AI. We are developing Mammoptix together with leading university engineers, an established medical-grade hardware partner and respected clinical advisors, with the support of Europe and the Flemish government innovation funding (VLAIO).

bottom of page